legislation: 110-hr-6486
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110-hr-6486 | 110 | hr | 6486 | Drug Testing Integrity Act of 2008 | Crime and Law Enforcement | 2008-07-14 | 2008-07-14 | Referred to the House Committee on Energy and Commerce. | House | Rep. Engel, Eliot L. [D-NY-17] | NY | D | E000179 | 4 | Drug Testing Integrity Act of 2008 - Makes it unlawful to knowingly manufacture, market, sell, ship, or otherwise provide to another individual any product with the intent to assist such individual to use such product to defraud a drug test. Defines "defraud a drug test" to mean to: (1) submit a substance that purports to be from an individual other than its actual source, or purports to have been excreted or collected other than when it was actually excreted or collected; or (2) engage in any other conduct with the intent to produce a false or misleading outcome of a test for the presence of a controlled substance. Grants the Federal Trade Commission (FTC) enforcement powers as a violation of an unfair or deceptive act or practice. | 2019-11-15T21:22:03Z |